AUPH icon

Aurinia Pharmaceuticals
AUPH

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $21.7M invested in Aurinia Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$286K
2
+$36K
3
+$3.44K
4
Morgan Stanley
Morgan Stanley
New York
+$2.85K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.89K

Top Sellers

1
-$1.09M
2
-$581K
3
-$124
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.69M
2
$5.81M
3
$3.45M
4
$2.13M
5
$1.58M
6
$439K
7
$314K
8
$274K
9
$33K
10
$14K
11
$3K
12
$1K
13
$1K
14
–